The IRS announced a streamlined way for Employee Retention Credit claimants to extend the two-year deadline to file a refund suit after a claim disallowance.
AbbVie is setting up a shot to buy Kestrel Therapeutics down the line, as the biotech doses patients in a Phase 1 trial for the oral pan-KRAS inhibitor KST-6051 in solid tumors.
Weight loss giant Eli Lilly has penned a DNA editing deal with Profluent Bio, continuing its dealmaking spree as well as its commitment to artificial intelligence.
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
The new CEO has at least five years and a large M&A war chest to position Sanofi for life after the loss of exclusivity on its cornerstone immunology product.
The PCAOB found that audit committee chairs are increasingly turning to their auditors to understand AI’s impacts on a company’s financial reporting and controls.
The Financial Accounting Standards Board added a project to its technical agenda to allow insurance companies to use the “portfolio layer method” when doing hedge accounting on their financial liabilities.
The AICPA and CIMA announced its new “AI Skills Accelerator,” an intensive multicourse program that provides a wide breadth of materials to build skills with AI and better understand the mindset needed to do so successfully.